fluorouracil has been researched along with Germinoblastoma in 101 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of three 1-(halogenalkoxy)alkyl-5-fluorouracil derivatives on cultured mouse lymphoma cells were studied and compared with those of N-methyl-bis-(2-chloroethyl)amine hydrochloride (Lost)." | 7.68 | Effects of 1-(halogenalkoxy)alkyl-5-fluorouracil derivatives on cell growth, cell volume and nucleus size of mouse lymphoma cells. ( Jaeger, KH; Reitz, M, 1992) |
| "Uridine enhances the growth inhibition due to 5-fluorouracil (FUra) in a cultured mouse T-cell lymphoma (S-49)." | 7.67 | Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells. ( Klubes, P; Parker, WB, 1985) |
| ", 45:4249-4256, 1985) that uridine (10 microM) enhanced the cytotoxicity of 5-fluorouracil (FUra) in cultured mouse T-lymphoma (S-49) cells." | 7.67 | Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells. ( Kennedy, KA; Klubes, P; Parker, WB, 1987) |
| "The mouse T-lymphoma (S-49) cell line is useful for individually studying RNA- and DNA-directed effects of 5-fluoropyrimidines." | 7.66 | Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells. ( Day, JL; Mandel, HG; Maybaum, J; Sadee, W; Ullman, B, 1980) |
| "SUMMARY-A model has been derived for the effect of the chemotherapeutic agents cyclophosphamide (CY), 5-fluorouracil (5-FU), and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on the survival of mice bearing a transplantable lymphoma." | 7.64 | Survival of mice bearing a transplanted syngeneic lymphoma following treatment with cyclophosphamide, 5-fluorouracil, or 1,3-bis(2-chloroethyl)-1-nitrosourea. ( Bruce, WR; Meeker, BE; Valeriote, FA, 1967) |
| " This report describes a Phase Ib clinical trial investigating PG-11047 in combination with cytotoxic and anti-angiogenic chemotherapeutic agents in patients with advanced refractory metastatic solid tumors or lymphoma." | 7.01 | A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma. ( Becerra, CHR; Boyd, TE; Casero, RA; Conkling, PR; Fitzgerald, M; Garbo, LE; Jotte, RM; Marton, LJ; Murray Stewart, T; Richards, DA; Smith, DA; Stephenson, JJ; Vogelzang, NJ; Von Hoff, D; Wu, HH, 2021) |
| "At this juncture in the development of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ), knowledge about the agent's pharmacologic behavior and clinical antitumor activity in less common neoplasms is being elucidated." | 4.79 | Paclitaxel pharmacology and other tumor types. ( Rowinsky, EK, 1997) |
| " Here, we employed a lymphoma model to characterize tumor-associated circulating neutrophils, including their sensitivity to 5-fluorouracil (5-FU), busulfan (Bu) or treosulfan (Treo)." | 3.83 | Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice. ( Abedi-Valugerdi, M; Hassan, M; Pillai, PR; Sadeghi, B; Wolfsberger, J; Zhao, Y; Zheng, W, 2016) |
| "We pretreated cell lines derived from human melanomas, adenocarcinomas, and lymphomas with the PPIs omeprazole, esomeprazole, or pantoprazole and tested their response to cytotoxic drugs in cell death assays." | 3.72 | Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. ( Arancia, G; Belardelli, F; De Milito, A; Fais, S; Federici, C; Iessi, E; Logozzi, M; Lozupone, F; Luciani, F; Lugini, L; Marra, M; Molinari, A; Montinaro, A; Parmiani, G; Rivoltini, L; Spada, M, 2004) |
| "A treatment schedule for primary intraocular lymphoma consisting of methotrexate intravitreal injections every 48 to 72 hours provides therapeutic drug concentrations in the vitreous and, in combination with fluorouracil and dexamethasone, appears to be safe in the rabbit eye." | 3.71 | Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. ( Chan, CC; Nussenblatt, RB; Reed, GF; Robinson, MR; Sung, C; Tansey, G; Velez, G; Yuan, P, 2001) |
| "The effects of three 1-(halogenalkoxy)alkyl-5-fluorouracil derivatives on cultured mouse lymphoma cells were studied and compared with those of N-methyl-bis-(2-chloroethyl)amine hydrochloride (Lost)." | 3.68 | Effects of 1-(halogenalkoxy)alkyl-5-fluorouracil derivatives on cell growth, cell volume and nucleus size of mouse lymphoma cells. ( Jaeger, KH; Reitz, M, 1992) |
| "From wild type mouse lymphoma cells, a clone, (FURT-1A), was isolated by virtue of its resistance to 1 microM 5-fluorouracil and 10 microM thymidine." | 3.67 | Biochemical phenotype of 5-fluorouracil-resistant murine T-lymphoblasts with genetically altered CTP synthetase activity. ( Aronow, B; Lassetter, J; Ullman, B; Washtien, W; Watts, T, 1984) |
| "Uridine enhances the growth inhibition due to 5-fluorouracil (FUra) in a cultured mouse T-cell lymphoma (S-49)." | 3.67 | Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells. ( Klubes, P; Parker, WB, 1985) |
| "From wildtype mouse lymphoma cells, a clone (FURT-1A), was isolated by virtue of its resistance to 1 microM 5-fluorouracil." | 3.67 | Mammalian mutants genetically altered in CTP synthetase activity. ( Aronow, B; Ullman, B, 1986) |
| ", 45:4249-4256, 1985) that uridine (10 microM) enhanced the cytotoxicity of 5-fluorouracil (FUra) in cultured mouse T-lymphoma (S-49) cells." | 3.67 | Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells. ( Kennedy, KA; Klubes, P; Parker, WB, 1987) |
| "Seven patients with advanced cutaneous T-cell lymphomas were treated with a combination chemotherapy regimen of vincristine, doxorubicin (Adriamycin), bleomycin, methotrexate, leucovorin factor, 5-FU, and hydrocortisone." | 3.66 | Combination chemotherapy for advanced cutaneous T-cell lymphomas. ( Edelson, RL; Lo Gerfo, P; Oster, MW; Raafat, J, 1980) |
| "The mouse T-lymphoma (S-49) cell line is useful for individually studying RNA- and DNA-directed effects of 5-fluoropyrimidines." | 3.66 | Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells. ( Day, JL; Mandel, HG; Maybaum, J; Sadee, W; Ullman, B, 1980) |
| "The combined effect of the polysaccharide levan (previously shown to exert a host-dependent as well as direct antitumoural activity) and the cytotoxic agents cyclophosphamide (CY), methotrexate (MTX), vincristine (VINC) and 5-fluoro-uracil (SFU) was studied in Lewis lung carcinoma and AKR lymphoma." | 3.66 | Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice. ( Leibovici, J; Stark, Y; Wolman, M, 1983) |
| "SUMMARY-A model has been derived for the effect of the chemotherapeutic agents cyclophosphamide (CY), 5-fluorouracil (5-FU), and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on the survival of mice bearing a transplantable lymphoma." | 3.64 | Survival of mice bearing a transplanted syngeneic lymphoma following treatment with cyclophosphamide, 5-fluorouracil, or 1,3-bis(2-chloroethyl)-1-nitrosourea. ( Bruce, WR; Meeker, BE; Valeriote, FA, 1967) |
| " This report describes a Phase Ib clinical trial investigating PG-11047 in combination with cytotoxic and anti-angiogenic chemotherapeutic agents in patients with advanced refractory metastatic solid tumors or lymphoma." | 3.01 | A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma. ( Becerra, CHR; Boyd, TE; Casero, RA; Conkling, PR; Fitzgerald, M; Garbo, LE; Jotte, RM; Marton, LJ; Murray Stewart, T; Richards, DA; Smith, DA; Stephenson, JJ; Vogelzang, NJ; Von Hoff, D; Wu, HH, 2021) |
| " The treatment plan consisted of weekly gemcitabine for three weeks with twice daily dosing of 5-FU and eniluracil for 21 days beginning on day one of gemcitabine." | 2.70 | Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy. ( Alberti, D; Arzoomanian, RZ; Bailey, H; Berlin, JD; Binger, K; Feierabend, C; Marrocha, R; Morgan-Meadows, S; Mulkerin, D; Thomas, JP; Volkman, J; Wilding, G, 2002) |
| "Vomiting was not consistently related to the excretion of either catecholamine." | 2.67 | Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. ( Börjesson, S; Fredrikson, M; Fürst, CJ; Hursti, TJ; Peterson, C; Steineck, G, 1994) |
| "From 23 patients with advanced non-Hodgkin lymphomas of a high malignancy 11 received a therapy with CVPP scheme; 2 of them came into a complete remission and 3 of them into a partial one." | 2.65 | [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study]. ( Anger, G; Fink, R; Höche, D, 1980) |
| "Pathological diagnosis was carcinoid, se, ly2, v0, n1." | 1.56 | [A Case of Malignant Lymphoma Undergoing HAI Treatment for Multiple Liver Metastases of Carcinoid That Appeared about Nine Years after Resection of Rectal Carcinoid with Liver Metastases]. ( Gofuku, J; Hasuike, Y; Higuchi, I; Ishikawa, A; Miyamoto, M; Mori, Y; Tokunaga, M; Tsuchida, Y; Urano, N, 2020) |
| "5-fluorouracil (5-FU) has been successfully used to control (or cure) a variety of tumors, but has been only rarely applied to tumors of the lymphoid lineage." | 1.32 | Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivo. ( D'Costa, S; Hurwitz, JL, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 65 (64.36) | 18.7374 |
| 1990's | 9 (8.91) | 18.2507 |
| 2000's | 15 (14.85) | 29.6817 |
| 2010's | 8 (7.92) | 24.3611 |
| 2020's | 4 (3.96) | 2.80 |
| Authors | Studies |
|---|---|
| Vijay Avin, BR | 1 |
| Thirusangu, P | 1 |
| Lakshmi Ranganatha, V | 1 |
| Firdouse, A | 1 |
| Prabhakar, BT | 1 |
| Khanum, SA | 1 |
| Santiago-Vazquez, Y | 1 |
| Das, S | 1 |
| Das, U | 1 |
| Robles-Escajeda, E | 1 |
| Ortega, NM | 1 |
| Lema, C | 1 |
| Varela-Ramírez, A | 1 |
| Aguilera, RJ | 1 |
| Balzarini, J | 1 |
| De Clercq, E | 1 |
| Dimmock, SG | 1 |
| Gorecki, DK | 1 |
| Dimmock, JR | 1 |
| Pilot, T | 1 |
| Fratti, A | 1 |
| Thinselin, C | 1 |
| Perrichet, A | 1 |
| Demontoux, L | 1 |
| Limagne, E | 1 |
| Derangère, V | 1 |
| Ilie, A | 1 |
| Ndiaye, M | 1 |
| Jacquin, E | 1 |
| Garrido, C | 1 |
| Ghiringhelli, F | 1 |
| Chalmin, F | 1 |
| Rébé, C | 1 |
| Hasuike, Y | 1 |
| Higuchi, I | 1 |
| Mori, Y | 1 |
| Ishikawa, A | 1 |
| Urano, N | 1 |
| Gofuku, J | 1 |
| Tsuchida, Y | 1 |
| Miyamoto, M | 1 |
| Tokunaga, M | 1 |
| Murray Stewart, T | 1 |
| Von Hoff, D | 1 |
| Fitzgerald, M | 1 |
| Marton, LJ | 1 |
| Becerra, CHR | 1 |
| Boyd, TE | 1 |
| Conkling, PR | 1 |
| Garbo, LE | 1 |
| Jotte, RM | 1 |
| Richards, DA | 1 |
| Smith, DA | 1 |
| Stephenson, JJ | 1 |
| Vogelzang, NJ | 1 |
| Wu, HH | 1 |
| Casero, RA | 1 |
| Chong, SJF | 1 |
| Iskandar, K | 1 |
| Lai, JXH | 1 |
| Qu, J | 1 |
| Raman, D | 1 |
| Valentin, R | 1 |
| Herbaux, C | 1 |
| Collins, M | 1 |
| Low, ICC | 1 |
| Loh, T | 1 |
| Davids, M | 1 |
| Pervaiz, S | 1 |
| Abedi-Valugerdi, M | 3 |
| Zheng, W | 2 |
| Benkessou, F | 1 |
| Zhao, Y | 2 |
| Hassan, M | 3 |
| Shariatpanahi, SP | 2 |
| Madjidzadeh, K | 1 |
| Orecchioni, S | 1 |
| Talarico, G | 1 |
| Labanca, V | 1 |
| Calleri, A | 1 |
| Mancuso, P | 1 |
| Bertolini, F | 1 |
| Reneeta, NP | 1 |
| Thiyonila, B | 1 |
| Aathmanathan, VS | 1 |
| Ramya, T | 1 |
| Chandrasekar, P | 1 |
| Subramanian, N | 1 |
| Prajapati, VK | 1 |
| Krishnan, M | 1 |
| Smith, SA | 1 |
| Auseon, AJ | 1 |
| Wolfsberger, J | 1 |
| Pillai, PR | 1 |
| Sadeghi, B | 1 |
| Bruce, WR | 4 |
| Valeriote, FA | 1 |
| Meeker, BE | 2 |
| Saiko, P | 2 |
| Ozsvar-Kozma, M | 1 |
| Graser, G | 1 |
| Lackner, A | 1 |
| Grusch, M | 2 |
| Madlener, S | 2 |
| Krupitza, G | 2 |
| Jaeger, W | 1 |
| Hidvegi, M | 1 |
| Agarwal, RP | 1 |
| Fritzer-Szekeres, M | 2 |
| Szekeres, T | 2 |
| Waller, EK | 1 |
| Barlett, N | 1 |
| Chen, CH | 1 |
| Mujic, V | 1 |
| Sussman, H | 1 |
| Toepker, S | 1 |
| Grenier, K | 1 |
| Morgan-Meadows, S | 1 |
| Thomas, JP | 1 |
| Mulkerin, D | 1 |
| Berlin, JD | 1 |
| Bailey, H | 1 |
| Binger, K | 1 |
| Volkman, J | 1 |
| Alberti, D | 1 |
| Feierabend, C | 1 |
| Marrocha, R | 1 |
| Arzoomanian, RZ | 1 |
| Wilding, G | 1 |
| Christina, AJ | 1 |
| Alwin Jose, M | 1 |
| Heison Robert, SJ | 1 |
| Kothai, R | 1 |
| Chidambaranathan, N | 1 |
| Muthumani, P | 1 |
| D'Costa, S | 1 |
| Hurwitz, JL | 1 |
| KIDD, JG | 1 |
| LAMPKIN-HIBBARD, JM | 1 |
| MUKHERJEE, KL | 1 |
| HEIDELBERGER, C | 1 |
| ROOSA, RA | 1 |
| BRADLEY, TR | 1 |
| LAW, LW | 1 |
| HERZENBERG, LA | 1 |
| MACLEOD, RM | 1 |
| KING, CE | 1 |
| HOLLANDER, VP | 1 |
| KASBEKAR, DK | 1 |
| GREENBERG, DM | 1 |
| BOOTH, BA | 1 |
| SARTORELLI, AC | 1 |
| FALKSON, G | 1 |
| SNYMAN, HJ | 1 |
| KARNOFSKY, DA | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| ROCHLIN, DB | 1 |
| SMART, CR | 1 |
| SILVA, A | 1 |
| BAKER, RR | 1 |
| GAERTNER, RA | 1 |
| Dummer, R | 1 |
| Beyeler, M | 1 |
| Morcinek, J | 1 |
| Burg, G | 1 |
| Oelmann, E | 1 |
| Haghgu, S | 1 |
| Kulimova, E | 1 |
| Mesters, RM | 1 |
| Kienast, J | 1 |
| Herbst, H | 1 |
| Schmitmann, C | 1 |
| Kolkmeyer, A | 1 |
| Serve, H | 1 |
| Berdel, WE | 1 |
| Luciani, F | 1 |
| Spada, M | 1 |
| De Milito, A | 1 |
| Molinari, A | 1 |
| Rivoltini, L | 1 |
| Montinaro, A | 1 |
| Marra, M | 1 |
| Lugini, L | 1 |
| Logozzi, M | 1 |
| Lozupone, F | 1 |
| Federici, C | 1 |
| Iessi, E | 1 |
| Parmiani, G | 1 |
| Arancia, G | 1 |
| Belardelli, F | 1 |
| Fais, S | 1 |
| Bauer, W | 1 |
| Horvath, Z | 1 |
| Hoechtl, T | 1 |
| Illmer, C | 1 |
| Mader, RM | 1 |
| Schott, H | 1 |
| Correale, P | 1 |
| Del Vecchio, MT | 1 |
| Di Genova, G | 1 |
| Savellini, GG | 1 |
| La Placa, M | 1 |
| Terrosi, C | 1 |
| Vestri, M | 1 |
| Urso, R | 1 |
| Lemonnier, F | 1 |
| Aquino, A | 1 |
| Bonmassar, E | 2 |
| Giorgi, G | 1 |
| Francini, G | 1 |
| Cusi, MG | 1 |
| Jones, B | 1 |
| Dale, RG | 1 |
| Gaya, AM | 1 |
| Li, ML | 2 |
| Li, CG | 2 |
| Shu, XH | 2 |
| Li, MX | 1 |
| Jia, YJ | 1 |
| Qin, ZH | 2 |
| Liu, YJ | 1 |
| Michael, N | 1 |
| Madoc-Jones, H | 1 |
| Takeuchi, S | 1 |
| Akahoshi, Y | 1 |
| Kasai, C | 1 |
| Nishimoto, Y | 1 |
| Höche, D | 1 |
| Fink, R | 1 |
| Anger, G | 1 |
| Raafat, J | 1 |
| Oster, MW | 1 |
| Lo Gerfo, P | 1 |
| Edelson, RL | 1 |
| Namba, M | 1 |
| Miyoshi, T | 1 |
| Kanamori, T | 1 |
| Nobuhara, M | 1 |
| Kimoto, T | 1 |
| Ogawa, S | 1 |
| Matsumoto, K | 1 |
| Tabuchi, K | 1 |
| Furuta, T | 1 |
| Fujiwara, T | 1 |
| Nakasone, S | 1 |
| Ohnishi, R | 1 |
| Moriya, Y | 1 |
| Nishimoto, A | 1 |
| Doi, A | 1 |
| Asari, S | 1 |
| Kasajima, T | 1 |
| Yamakawa, M | 1 |
| Maeda, K | 1 |
| Matsuda, M | 1 |
| Dobashi, M | 1 |
| Imai, Y | 1 |
| Maybaum, J | 2 |
| Ullman, B | 4 |
| Mandel, HG | 1 |
| Day, JL | 2 |
| Sadee, W | 3 |
| Aronow, B | 2 |
| Watts, T | 1 |
| Lassetter, J | 1 |
| Washtien, W | 1 |
| Bedikian, AY | 1 |
| Chen, TT | 1 |
| Khankhanian, N | 1 |
| Heilbrun, LK | 1 |
| McBride, CM | 1 |
| McMurtrey, MJ | 1 |
| Bodey, GP | 1 |
| Leibovici, J | 1 |
| Stark, Y | 1 |
| Wolman, M | 1 |
| Cohen, MB | 1 |
| Cassone, A | 2 |
| Bistoni, F | 2 |
| Cenci, E | 2 |
| Pesce, CD | 1 |
| Tissi, L | 2 |
| Marconi, P | 2 |
| Oda, Y | 1 |
| Mori, K | 1 |
| Tsuda, E | 1 |
| Tokuriki, Y | 1 |
| Tsuda, T | 1 |
| Jurga, L | 1 |
| Mrinák, J | 1 |
| Ponist, J | 1 |
| Sefara, P | 1 |
| Berc, A | 1 |
| Delfina Pesce, C | 1 |
| Boccanera, M | 1 |
| Kanzawa, F | 1 |
| Hoshi, A | 1 |
| Kuretani, K | 1 |
| Woodcock, TM | 1 |
| Martin, DS | 1 |
| Damin, LA | 1 |
| Kemeny, NE | 1 |
| Young, CW | 1 |
| Fredrikson, M | 1 |
| Hursti, TJ | 1 |
| Steineck, G | 1 |
| Fürst, CJ | 1 |
| Börjesson, S | 1 |
| Peterson, C | 1 |
| Kelliher, MA | 1 |
| Weckstein, DJ | 1 |
| Knott, AG | 1 |
| Wortis, HH | 1 |
| Rosenberg, N | 1 |
| Rowinsky, EK | 1 |
| Yeh, KH | 1 |
| Yeh, SH | 1 |
| Chang, YS | 1 |
| Cheng, AL | 1 |
| Kawamura, K | 1 |
| Tasaki, K | 1 |
| Hamada, H | 1 |
| Takenaga, K | 1 |
| Sakiyama, S | 1 |
| Tagawa, M | 1 |
| Velez, G | 1 |
| Yuan, P | 1 |
| Sung, C | 1 |
| Tansey, G | 1 |
| Reed, GF | 1 |
| Chan, CC | 1 |
| Nussenblatt, RB | 1 |
| Robinson, MR | 1 |
| Levinson, BB | 1 |
| Martin, DW | 1 |
| Kopper, L | 1 |
| Jeney, A | 1 |
| Lapis, K | 2 |
| Török, M | 1 |
| Testorelli, C | 1 |
| Franco, P | 1 |
| Goldin, A | 2 |
| Cudkowicz, G | 1 |
| Guglielmi, C | 2 |
| Amadori, S | 2 |
| Martelli, M | 1 |
| Papa, G | 2 |
| Mandelli, F | 2 |
| Saito, T | 1 |
| Otaka, T | 1 |
| Sato, H | 1 |
| Reitz, M | 1 |
| Jaeger, KH | 1 |
| Shinomiya, N | 1 |
| Katsura, Y | 1 |
| Tsugita, M | 1 |
| Noritake, M | 1 |
| Tsuru, S | 1 |
| Inedjian, JM | 1 |
| Thomassin, JM | 1 |
| Danoy, MC | 1 |
| Sermet, M | 1 |
| Geunoun, A | 1 |
| Parker, WB | 2 |
| Klubes, P | 2 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Takahashi, T | 1 |
| Palmeri, S | 1 |
| Trave, F | 1 |
| Russello, O | 1 |
| Rustum, YM | 1 |
| Singh, UP | 1 |
| Ghose, R | 1 |
| Ghose, AK | 1 |
| Sodhi, A | 1 |
| Singh, SM | 1 |
| Singh, RK | 1 |
| Love, RR | 1 |
| Leventhal, H | 1 |
| Easterling, DV | 1 |
| Nerenz, DR | 1 |
| Gorelik, E | 1 |
| Ovejera, A | 1 |
| Shoemaker, R | 1 |
| Jarvis, A | 1 |
| Alley, M | 1 |
| Duff, R | 1 |
| Mayo, J | 1 |
| Herberman, R | 1 |
| Boyd, M | 1 |
| Kennedy, KA | 1 |
| Wilmanns, W | 1 |
| Binsack, T | 1 |
| Sauer, H | 1 |
| Marcovitch, S | 1 |
| Keisari, Y | 1 |
| Anselmo, AP | 1 |
| Cimino, G | 1 |
| Ruco, LP | 1 |
| Biagini, C | 1 |
| Uemura, T | 1 |
| Amba, T | 1 |
| Hamada, M | 1 |
| Tanaka, S | 1 |
| Tashima, CK | 1 |
| Bergsagel, DE | 1 |
| Reyes, P | 1 |
| Hall, TC | 1 |
| Moskalik, KG | 1 |
| Kozlov, AP | 1 |
| Akimov, AA | 1 |
| Frei, E | 1 |
| Schabel, FM | 1 |
| Maruyama, Y | 1 |
| Lee, TC | 1 |
| Sullivan, S | 1 |
| Morrone, G | 1 |
| Ota, K | 2 |
| Goldfinger, D | 1 |
| McGinniss, MH | 1 |
| Scherer, E | 1 |
| Rassow, J | 1 |
| Almersjö, O | 1 |
| Bengmark, S | 1 |
| Rudenstam, CM | 1 |
| Hafström, L | 1 |
| Nilsson, LA | 1 |
| Vietti, T | 1 |
| Eggerding, F | 1 |
| Valeriote, F | 1 |
| Klein, E | 1 |
| Clarkson, B | 1 |
| Ohkita, T | 1 |
| O'Connor, A | 1 |
| Benedeczky, I | 1 |
9 reviews available for fluorouracil and Germinoblastoma
| Article | Year |
|---|---|
Chemotherapy-induced takotsubo cardiomyopathy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Echo | 2013 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio | 2003 |
Paclitaxel pharmacology and other tumor types.
Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols | 1997 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Emulsion and activated carbon in cancer chemotherapy.
Topics: Administration, Oral; Adult; Aged; Animals; Bleomycin; Breast Neoplasms; Carbon; Clinical Trials as | 1986 |
An assessment of massive-dose chemotherapy of malignant disease.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Division; Cyclo | 1971 |
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
[Cytostatic chemotherapy of neoplasms in children].
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; | 1971 |
Multiple combination therapy in cancer chemotherapy in Japan.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug | 1969 |
6 trials available for fluorouracil and Germinoblastoma
| Article | Year |
|---|---|
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplat | 2021 |
Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Fluorou | 2002 |
[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
Topics: Bleomycin; Cell Division; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Hodgkin D | 1980 |
Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Circadian Rhythm; Cis | 1994 |
F-MACHOP in advanced aggressive lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Do | 1992 |
Emulsion and activated carbon in cancer chemotherapy.
Topics: Administration, Oral; Adult; Aged; Animals; Bleomycin; Breast Neoplasms; Carbon; Clinical Trials as | 1986 |
87 other studies available for fluorouracil and Germinoblastoma
| Article | Year |
|---|---|
Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Carcinoma, Ehrlic | 2014 |
Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dimerization; Dose-Response | 2014 |
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Caspase 1; Enzyme Activation; Female; Fluorouracil; Heat-S | 2020 |
[A Case of Malignant Lymphoma Undergoing HAI Treatment for Multiple Liver Metastases of Carcinoid That Appeared about Nine Years after Resection of Rectal Carcinoid with Liver Metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Chemoembolization, Therapeuti | 2020 |
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism.
Topics: Apoptosis; Cell Proliferation; Cisplatin; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etopos | 2020 |
Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocyt | 2017 |
Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Topics: Algorithms; Animals; Antineoplastic Agents; Arginine; Fluorouracil; Humans; Immune Tolerance; Immuni | 2018 |
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.
Topics: Animals; B7-H1 Antigen; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Fluorouracil; Humans; | 2018 |
Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; Bombyx; Cell Line, Tumor; Cell Pr | 2018 |
Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 2016 |
Survival of mice bearing a transplanted syngeneic lymphoma following treatment with cyclophosphamide, 5-fluorouracil, or 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Fluor | 1967 |
Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dose | 2009 |
Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 1999 |
Effect of Indigofera aspalathoides against Dalton's ascitic lymphoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Ascites; Fluorouracil; Indigofera; Injections, Intraperi | 2003 |
Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal; CD40 Antigens; Cell Division; Cell Membrane; Drug Synergism; Fluoro | 2003 |
Effects of arsenic-azoproteins on mouse lymphoma cells in vivo; with observations on the effects of other anti-lymphoma agents, and on the susceptibility to these effects of lymphoma cells of various types.
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenicals; Fluorouracil; Guinea Pigs; Lymphoma; Mice; Neop | 1958 |
Effect of steroids and fluoropyrimidines on lymphomas. II. In vivo studies on tumor resistance and collateral sensitivity.
Topics: Antimetabolites; DNA; DNA, Neoplasm; Fludrocortisone; Fluorouracil; Humans; Lymphoma; RNA; RNA, Neop | 1963 |
Characterization of resistance to amethopterin, 8-azaguanine and several fluorinated pyrimidines in the murine lymphocytic neoplasm, P388.
Topics: Animals; Antineoplastic Agents; Azaguanine; Fluorouracil; Leukemia; Leukemia, Lymphoid; Lymphoma; Me | 1962 |
EFFECT OF CORTICOSTEROIDS ON RIBONUCLEASE AND NUCLEIC ACID CONTENT IN LYMPHOSARCOMA P1798.
Topics: Adrenal Cortex Hormones; Animals; Edetic Acid; Fluorouracil; Glucocorticoids; Lymphoma; Lymphoma, No | 1963 |
STUDIES ON TUMOR RESISTANCE TO 5-FLUOROURACIL.
Topics: Animals; Carbon Isotopes; Carboxy-Lyases; Fluorouracil; Genetics; Lymphoma; Lymphoma, Non-Hodgkin; M | 1963 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; | 1963 |
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; H | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
CHEMOTHERAPY OF MALIGNANCIES OF THE GASTROINTESTINAL TRACT.
Topics: Antineoplastic Agents; Carcinoid Tumor; Colonic Neoplasms; Cyclophosphamide; Fluorouracil; Gastroint | 1965 |
REGIONAL ARTERIAL INFUSION OF ANTIMETABOLITES. AN ANALYSIS OF THE RESULTS OBTAINED IN 33 PATIENTS WITH MALIGNANT TUMORS OF THE HEAD AND NECK.
Topics: Antimetabolites; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; H | 1965 |
Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro.
Topics: Cell Differentiation; Cell Division; Cell Line, Tumor; Fibroblast Growth Factor 7; Fibroblast Growth | 2004 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; C | 2004 |
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2005 |
Linear quadratic modeling of increased late normal-tissue effects in special clinical situations.
Topics: Aged; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosph | 2006 |
[Study of the immunological mechanism of anti-tumor effects of 5-FU by establishing EL4 tumor-bearing mouse models].
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship | 2007 |
[Relationships between tumor shrinkage and peripheral blood cell changes during tumor-rejection induced by a high dose of 5-FU in C57BL/6 mice].
Topics: Animals; Antimetabolites, Antineoplastic; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; | 2008 |
A model system for examining the action of anti-cancer agents at the cellular level in vivo.
Topics: Animals; Antineoplastic Agents; Azaserine; Cyclophosphamide; Dactinomycin; Fluorouracil; Hematopoies | 1967 |
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Fluorouracil; Hematopoietic System; Lymphoma; Mice | 1967 |
Sensitivity of L cells in exponential and stationary phase to 5-fluorouracil.
Topics: Animals; Culture Techniques; Fluorouracil; L Cells; Leukemia, Experimental; Lymphoma; Mice; Mitosis | 1967 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; | 1984 |
Combination chemotherapy for advanced cutaneous T-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluor | 1980 |
Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Drug Evaluation, Preclinical; Fibroblasts; Fluo | 1982 |
[Combination chemotherapy of brain tumors with ACNU and 5-FU].
Topics: Astrocytoma; Biological Products; Brain Neoplasms; Combined Modality Therapy; Drug Therapy, Combinat | 1983 |
[Effect of cepharanthin on peripheral leukocytopenia caused by antineoplastic agents].
Topics: Alkaloids; Animals; Benzylisoquinolines; Fluorouracil; Leukopenia; Lymphoma; Mice; Mice, Inbred Stra | 1983 |
Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
Topics: Animals; Cell Cycle; DNA, Neoplasm; Dose-Response Relationship, Drug; Floxuridine; Fluorouracil; Leu | 1980 |
Biochemical phenotype of 5-fluorouracil-resistant murine T-lymphoblasts with genetically altered CTP synthetase activity.
Topics: Animals; Carbon-Nitrogen Ligases; Cell Division; Cell Line; Clone Cells; Deoxyribonucleotides; Drug | 1984 |
The natural history of gastric cancer and prognostic factors influencing survival.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymphatic M | 1984 |
Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Co | 1983 |
In vivo rates of pyrimidine nucleotide metabolism in intact mouse T-lymphoma (s-49) cells treated with 5-fluorouracil.
Topics: Animals; Cell Line; Deoxyribonucleotides; DNA, Neoplasm; Fluorouracil; Kinetics; Lymphoma; Mathemati | 1981 |
Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Candida albicans; Carmustine; Cell Wall; Cry | 1982 |
[Non-surgically treated primary malignant lymphoma of the brain: recurrences in 2 occasions following the cessations of antineoplastic agent administration].
Topics: Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphoma; Mitomycins | 1982 |
Non-invasive methods for detection of cardiomyopathy in the course of antineoplastic treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Drug Therapy, Combination; F | 1982 |
[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
Topics: Adjuvants, Immunologic; Animals; Carmustine; Combined Modality Therapy; Female; Fluorouracil; Glucan | 1982 |
Influence of duration of exposure to 5-fluorouracil on antiproliferating activity against cultured murine lymphoma cells.
Topics: Animals; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fluorouracil; Lymphoma; M | 1981 |
Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
Topics: Adult; Aged; Bone Marrow; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Flu | 1980 |
ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.
Topics: Animals; Base Sequence; Bone Marrow; Cell Transformation, Neoplastic; Fluorouracil; Fusion Proteins, | 1993 |
Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: direct evidence from colony forming unit-granulocyte and monocyte (CFU-GM) clonogenic assay.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Breast Neoplasms; Colony-Forming Units Assay; Do | 2000 |
Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Escherichia coli; Fluorouracil; Lymphoma; | 2000 |
Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Chromatography, Hi | 2001 |
Pyrimidine pathway variants of cultured mouse lymphoma cells with altered levels of both orotate phosphoribosyltransferase and orotidylate decarboxylase.
Topics: Animals; Azauridine; Carboxy-Lyases; Cell Division; Cell Line; Fluorouracil; Kinetics; Lymphoma; Mic | 1979 |
Studies of the growth of an ascitic tumour. II. A system to study the tumour-age dependent effect of antitumour agents.
Topics: Alkylating Agents; Animals; Cell Division; Depression, Chemical; Dose-Response Relationship, Drug; F | 1978 |
Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Fluorouracil; His | 1975 |
[Nephrotic syndrome associated with neoplasms and malignant lymphoma].
Topics: Adult; Aged; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphoma; Male; Middle Aged; Mitomycin; | 1992 |
Effects of 1-(halogenalkoxy)alkyl-5-fluorouracil derivatives on cell growth, cell volume and nucleus size of mouse lymphoma cells.
Topics: Animals; Cell Division; Cell Nucleus; Fluorouracil; Lymphoma; Mice; Tumor Cells, Cultured | 1992 |
[Analysis of tumor cell growth and effects of antitumor drugs on cell cycle regulation by flow cytometry].
Topics: Animals; Cell Cycle; Cell Division; Cisplatin; Flow Cytometry; Fluorouracil; Interphase; Lymphoma; M | 1991 |
[Extraskeletal pharyngolaryngeal Ewing's sarcoma. Apropos of a case].
Topics: Adult; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Fluorouracil; Humans; Immunohi | 1991 |
Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
Topics: Animals; Cell Survival; Cells, Cultured; DNA; Fluorouracil; Lymphoma; Mice; Phosphoribosyl Pyrophosp | 1985 |
The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Dose-Response | 1989 |
The effect of histidine on the structure and antitumor activity of metal-5-halouracil complexes.
Topics: Animals; Bromouracil; Cadmium; Cobalt; Copper; Fluorouracil; Histidine; Lymphoma; Magnetics; Mangane | 1989 |
Side effects and emotional distress during cancer chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxor | 1989 |
Determination of 5-fluorouridine diphosphate glucose as a metabolite of 5-fluorouracil in mouse T-lymphoma (S-49) cells using high-performance liquid chromatography.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Deoxyuracil Nucleotides; Fluorodeoxy | 1986 |
Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines.
Topics: Animals; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Huma | 1987 |
Mammalian mutants genetically altered in CTP synthetase activity.
Topics: Animals; Biological Transport; Carbon-Nitrogen Ligases; Cell Cycle; Cell Line; Cytidine Triphosphate | 1986 |
Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
Topics: Animals; Cell Survival; Chromatography, High Pressure Liquid; Colony-Forming Units Assay; Crotalid V | 1987 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dac | 1985 |
The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cytotoxicity, Immunologic; Dactinomycin; Dose-R | 1985 |
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 1985 |
[Treatment of terminal cancer and relapsed cancer by 5-5-FU(5-fluorouracil)].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lymphoma; M | 1968 |
Hypercalcemia in cancer: response to therapy.
Topics: Adenocarcinoma; Adult; Allopurinol; Antineoplastic Agents; Calcium; Cyclophosphamide; Fluorouracil; | 1974 |
Synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice.
Topics: Animals; Fluorouracil; Leukemia L1210; Lymphoma; Mice; Neoplasm Transplantation; Neoplasms, Experime | 1969 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Age cohort variation of tumor cells.
Topics: Animals; Cell Division; Disease Models, Animal; DNA, Neoplasm; Fluorouracil; Hydroxyurea; Lymphoma; | 1973 |
Advanced cancer: New concepts of medical therapy.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Choriocarcinoma; Colonic Neopl | 1973 |
Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antibodies; Antibody Formation; Blood Group Incompatibili | 1971 |
[Basic principles of percutaneous radiotherapy in cervical lymph node metastases].
Topics: Carcinoma, Squamous Cell; Cesium Isotopes; Cobalt Isotopes; Electrons; Fluorouracil; Head and Neck N | 1971 |
Evaluation of hepatic dearterialization in primary and secondary cancer of the liver.
Topics: Adult; Aged; Female; Fluorouracil; Hepatic Artery; Humans; Ligation; Liver; Liver Neoplasms; Lymphom | 1972 |
Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells.
Topics: Animals; Bone Marrow Cells; Cell Line; Cell Survival; Clone Cells; Fluorouracil; In Vitro Techniques | 1971 |
Local chemotherapy of cutaneous neoplasms.
Topics: Adenocarcinoma; Allergy and Immunology; Antineoplastic Agents; Carcinoma, Squamous Cell; Dactinomyci | 1970 |
Kinetics of proliferation of cancer cells in neoplastic effusions in man.
Topics: Adenocarcinoma; Antineoplastic Agents; Autoradiography; Cell Division; DNA, Neoplasm; Exudates and T | 1965 |
Antimetabolite-induced changes in the fine structure of tumour cells.
Topics: Animals; Ascites; Fluorouracil; Lymphoma; Mice; Microscopy, Electron | 1966 |